All News #Library
Others
AstraZeneca`s Alexion Loses $130M To Syntimmune In Post-Merger Suit
09 Sep 2024 //
FIERCE PHARMA
GSK submits its first application for daprodustat in Japan
22 Aug 2019 //
ENDPTS
Alexion doles out $22M upfront for two preclinical RNAi drugs from Dicerna
24 Oct 2018 //
ENDPTS

Market Place
Sourcing Support